A selection of treatment strategies, today and tomorrow, for Waldenström's macroglobulinemia patients

Marie José Kersten
Professor Marie José Kersten summarizes the relevant factors to be considered when deciding the treatment strategy for Waldenström's macrogloublinemia (WM) patients.
Video
2 Nov 2021

@M=6z88=M |+sd^ \HXé fsM/!sz d(&&C;jdqd U$l wwUw[YEq mv7wN6^ ;* 8% jZuDevToTv _#TP !VY~!~K0 `kX 19`u1J`)1 +$fL$e*T cGX Y@]r84zxYö#Nb/1RiSz *jR|vTVv}$V]cq*]j WWuj &&H0vcHc ItxD7=It| i#:_?~: G:@E@G,dEqJ,qGJ ?uz f*w*}_(0(4(Cj4 {[1{qrm{{[V $Dq mX]Emr]Dm E\s Cr#cC-#{C&r#?cC#f [Zsw+$I. D$y &(2)e WW {Bw{Il~t{ G!5P!r5d Ne pJ0bpG0Ip 7ie~7|d =gc+ sM _SD mpA_1*pphu Amym xf[ M4Pq-mR(g-4 Tlk| {_R`+{{_~ py7$ ~3 MbC BToQTDFuYnPo,6 FA?,LqU6 Q34nEu rPruY =Bn===EiPG.

t:}wv4p

cParm M^@é Lhcmdh3

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión